Isoniazid Mediates the CYP2B6*6 Genotype-Dependent Interaction between Efavirenz and Antituberculosis Drug Therapy through Mechanism-Based Inactivation of CYP2A6

Court, Michael H.; Almutairi, Fawziah E.; Greenblatt, David J.; Hazarika, Suwagmani; Sheng, Hongyan; Klein, Kathrin; Zanger, Ulrich M.; Bourgea, Joanne; Patten, Christopher J.; Kwara, Awewura

dc.contributor.author	Klein, Kathrin	de_DE
dc.contributor.author	Zanger, Ulrich M.	de_DE
dc.date.accessioned	2014-10-30T14:45:58Z
dc.date.available	2014-10-30T14:45:58Z
dc.date.issued	2014	de_DE
dc.identifier.issn	0066-4804	de_DE
dc.identifier.uri	http://hdl.handle.net/10900/57266
dc.language.iso	en	de_DE
dc.publisher	Amer Soc Microbiology	de_DE
dc.relation.uri	http://dx.doi.org/10.1128/AAC.02532-14	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Isoniazid Mediates the CYP2B6*6 Genotype-Dependent Interaction between Efavirenz and Antituberculosis Drug Therapy through Mechanism-Based Inactivation of CYP2A6	de_DE
dc.type	Article	de_DE
utue.quellen.id	20141022002833_00624	de_DE
utue.publikation.seiten	4145-4152	de_DE
utue.personen.roh	Court, Michael H.	de_DE
utue.personen.roh	Almutairi, Fawziah E.	de_DE
utue.personen.roh	Greenblatt, David J.	de_DE
utue.personen.roh	Hazarika, Suwagmani	de_DE
utue.personen.roh	Sheng, Hongyan	de_DE
utue.personen.roh	Klein, Kathrin	de_DE
utue.personen.roh	Zanger, Ulrich M.	de_DE
utue.personen.roh	Bourgea, Joanne	de_DE
utue.personen.roh	Patten, Christopher J.	de_DE
utue.personen.roh	Kwara, Awewura	de_DE
dcterms.isPartOf.ZSTitelID	Antimicrobial Agents and Chemotherapy	de_DE
dcterms.isPartOf.ZS-Issue	7	de_DE
dcterms.isPartOf.ZS-Volume	58	de_DE
utue.fakultaet	Universität Tübingen (ohne Fakultätsangabe)	de_DE